US · Healthcare

Myriad Genetics Inc (MYGN)

Diagnostics & Research

Myriad Genetics Inc (MYGN) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MYGN

P/E ratio

18.00

Myriad Genetics Inc (MYGN) — FAQ

What is MYGN's P/E ratio?

The price-to-earnings (P/E) ratio for Myriad Genetics Inc (MYGN) is 18.00 (data as of 2026-03-24).

Does Myriad Genetics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Myriad Genetics Inc (MYGN). Check the MyAverix Finance app for the latest dividend data.

What sector is Myriad Genetics Inc in?

Myriad Genetics Inc (MYGN) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is MYGN listed on?

MYGN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)